# Arbutus Biopharma Corp: Form SCHEDULE 13D/A, filed Apr 28, 2026

- Company: [Arbutus Biopharma Corp](/companies/abus.md) (CIK 1447028)
- Form: SCHEDULE 13D/A
- Filed: 2026-04-28
- Accepted by EDGAR: Apr 28, 2026, 17:54 ET
- Period: not reported
- Accession: 0000921895-26-001101
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1447028/000092189526001101/xslSCHEDULE_13D_X02/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1447028/000092189526001101/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1447028/000092189526001101/xslSCHEDULE_13D_X02/primary_doc.xml

Filed Apr 28, 2026.
Source: SEC EDGAR, the filing index for accession 0000921895-26-001101. Last ingested by Listed: Oct 27, 2026, 17:27 ET. No prices; not investment advice.